aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Ionix Medical is a privately held medical device company based in Minneapolis, Minnesota, focused on developing next-generation minimally-invasive prostate treatments. Their proprietary technology aims to ablate both benign and malignant tissues using direct current, offering a novel solution for prostate health.
Ionix Medical has made significant strides in medical innovation, contributing to advancements in prostate treatment. Their cutting-edge technology promises to improve patient outcomes and reduce the invasiveness of traditional procedures.
Operating Status
Active
Ownership Type(s)
Private
Main Product(s)
Medical Devices
Technology
Technology
Tags
Healthtech
Model Types
Hardware
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was Ionix Medical founded?
Ionix Medical was founded in 2001.
Where is Ionix Medical's headquarters located?
Ionix Medical's headquarters is located in Maple Grove, MN, US.
When was Ionix Medical's last funding round?
Ionix Medical's most recent funding round was for $18.3M (USD) in September 2009.
How many employees does Ionix Medical have?
Ionix Medical has 6 employees as of Feb 5, 2024.
How much has Ionix Medical raised to-date?
As of July 05, 2023, Ionix Medical has raised a total of $18.3M (USD) since Sep 20, 2009.
Add Comparison
Total Raised to Date
$18.3M
USD
Last Update Sep 20, 2009
Last Deal Details
$18.3M
USD
Sep 20, 2009
Series Unknown
Total Employees Over Time
6
As of Feb 2024
Ionix Medical Address
6901 East Fish Lake Road
suite 188
Maple Grove,
Minnesota
55369
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts